Module 12 2019

New Problems Emerge ➢ As a result of new technologies and

innovations and electronic record keeping, the volume of information collected before, during and after the clinical trials continues to grow. ➢ LARGE amounts of data ➢ As such, comprehensive data collection and efficient management is now becoming a priority for pharmaceutical companies and clinical research organizations (CROs)

The Organisation for Professionals in Regulatory Affairs